Intravenous Dexrazoxane for Hemorrhagic Myocardial Infarction in STEMI: A Double-Blind, Placebo-Controlled, Sequential-Cohort Phase IIa Trial (SHIELD-MI)
31 August 2026 (12:00 - 12:15)
Organised by: 
Slides
About the speaker
Indiana University School of Medicine, Indianapolis (United States of America)
3 More presentations in this session
Professor A. Vincentelli (Lille, FR)
Access the full session
The Event
ESC Congress 2026
31 August 2026
12:00 CET
You may be interested in
Congress Presentation
Congress Session
Congress Presentation
